Literature DB >> 9734967

Protein-C concentrate for meningococcal purpura fulminans.

W Kreuz, A Veldman, C Escuriola-Ettingshausen, W Schneider, T Beeg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9734967     DOI: 10.1016/S0140-6736(05)60653-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Human protein C concentrate in the treatment of purpura fulminans: a retrospective analysis of safety and outcome in 94 pediatric patients.

Authors:  Alex Veldman; Doris Fischer; Flora Y Wong; Wolfhart Kreuz; Michael Sasse; Bruno Eberspächer; Ulrich Mansmann; Rudolf Schosser
Journal:  Crit Care       Date:  2010-08-19       Impact factor: 9.097

2.  Non Activated Protein C Supplementation in Septic Pediatric Hematological Patients.

Authors:  Teresa Perillo; Paola Muggeo; Giampaolo Arcamone; Francesco De Leonardis; Nicola Santoro
Journal:  Pediatr Rep       Date:  2016-06-15

3.  Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications.

Authors:  Paul N Knoebl
Journal:  Biologics       Date:  2008-06

Review 4.  Thrombosis in the critically ill neonate: incidence, diagnosis, and management.

Authors:  Alex Veldman; Marcel F Nold; Ina Michel-Behnke
Journal:  Vasc Health Risk Manag       Date:  2008

5.  An ADAM-10 dependent EPCR shedding links meningococcal interaction with endothelial cells to purpura fulminans.

Authors:  Hervé Lécuyer; Zoé Virion; Jean-Philippe Barnier; Soraya Matczak; Sandrine Bourdoulous; Elsa Bianchini; François Saller; Delphine Borgel; Xavier Nassif; Mathieu Coureuil
Journal:  PLoS Pathog       Date:  2018-04-09       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.